Commercially available cell-free permeability tests for industrial drug development: Increased sustainability through reduction of in vivo studies

AC Jacobsen, S Visentin, C Butnarasu, PC Stein… - Pharmaceutics, 2023 - mdpi.com
Replacing in vivo with in vitro studies can increase sustainability in the development of
medicines. This principle has already been applied in the biowaiver approach based on the …

[HTML][HTML] Reducing the environmental footprint of gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of …

ER de Santiago, M Dinis-Ribeiro, H Pohl… - …, 2022 - thieme-connect.com
Climate change and the destruction of ecosystems by human activities are among the
greatest challenges of the 21st century and require urgent action. Health care activities …

Describing the content of trial recruitment interventions using the TIDieR reporting checklist: a systematic methodology review

N Hudek, K Carroll, S Semchishen… - BMC Medical Research …, 2024 - Springer
Background Recruiting participants to clinical trials is an ongoing challenge, and relatively
little is known about what recruitment strategies lead to better recruitment. Recruitment …

[HTML][HTML] Artificial intelligence in the NHS: climate and emissions✰,✰✰

PS Bloomfield, P Clutton-Brock, E Pencheon… - The Journal of Climate …, 2021 - Elsevier
Healthcare provision has a significant climate impact and, conversely, the climate is a
determinant of population health. Research is underway to quantify the emissions from …

Reimagining research ethics to include environmental sustainability: a principled approach, including a case study of data-driven health research

G Samuel, C Richie - Journal of medical ethics, 2023 - jme.bmj.com
In this paper we argue the need to reimagine research ethics frameworks to include notions
of environmental sustainability. While there have long been calls for health care ethics …

Thinking health-related behaviors in a climate change context: a narrative review

G Chevance, U Fresán, E Hekler… - Annals of Behavioral …, 2023 - academic.oup.com
Background Human activities have changed the environment so profoundly over the past
two centuries that human-induced climate change is now posing serious health-related …

The future of clinical trials—is it virtual?

CE Ng, S Bowman, J Ling, R Bagshaw… - British Medical …, 2023 - academic.oup.com
Introduction Participant recruitment to clinical trials is often sub-optimal. Decentralized
clinical trials have the potential to address challenges in traditional site-based clinical trial …

The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance

JM Hoffmann, A Bauer, R Grossmann - BMJ Global Health, 2023 - gh.bmj.com
Introduction All economic sectors including the service sector, along with healthcare,
education and research, need to reduce their greenhouse gas emissions to limit global …

Carbon footprint of industry-sponsored late-stage clinical trials

N Mackillop, J Shah, M Collins, T Costelloe… - BMJ open, 2023 - bmjopen.bmj.com
Objectives To quantify the carbon footprint from a sample of pharma industry sponsored
phase III trials. To develop an approach that can readily be applied to future trials by …

[HTML][HTML] Climate toxicity: An increasingly relevant clinical issue in Cancer Care

CS Weadick, RJ Keogh, HK Carroll, S Boldrin… - Journal of Cancer …, 2023 - Elsevier
In recent years the terms time and financial toxicities have entered the vocabulary of cancer
care. We would like to introduce another toxicity: climate toxicity. Climate toxicity is a double …